BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 33962678)

  • 1. Repeated infusion of mesenchymal stem cells maintain the condition to inhibit deteriorated motor function, leading to an extended lifespan in the SOD1G93A rat model of amyotrophic lateral sclerosis.
    Magota H; Sasaki M; Kataoka-Sasaki Y; Oka S; Ukai R; Kiyose R; Onodera R; Kocsis JD; Honmou O
    Mol Brain; 2021 May; 14(1):76. PubMed ID: 33962678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model.
    Magota H; Sasaki M; Kataoka-Sasaki Y; Oka S; Ukai R; Kiyose R; Onodera R; Kocsis JD; Honmou O
    Brain Res; 2021 Apr; 1757():147296. PubMed ID: 33516815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice.
    Sironi F; Vallarola A; Violatto MB; Talamini L; Freschi M; De Gioia R; Capelli C; Agostini A; Moscatelli D; Tortarolo M; Bigini P; Introna M; Bendotti C
    Stem Cell Res; 2017 Dec; 25():166-178. PubMed ID: 29154076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
    Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
    Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1
    Bursch F; Rath KJ; Sarikidi A; Böselt S; Kefalakes E; Osmanovic A; Thau-Habermann N; Klöß S; Köhl U; Petri S
    J Tissue Eng Regen Med; 2019 Apr; 13(4):649-663. PubMed ID: 30811816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Combination of Intrathecal and Intramuscular Application of Human Mesenchymal Stem Cells Partly Reduces the Activation of Necroptosis in the Spinal Cord of SOD1
    Řehořová M; Vargová I; Forostyak S; Vacková I; Turnovcová K; Kupcová Skalníková H; Vodička P; Kubinová Š; Syková E; Jendelová P
    Stem Cells Transl Med; 2019 Jun; 8(6):535-547. PubMed ID: 30802001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis.
    Forostyak S; Jendelova P; Kapcalova M; Arboleda D; Sykova E
    Cytotherapy; 2011 Oct; 13(9):1036-46. PubMed ID: 21736505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.
    Chan-Il C; Young-Don L; Heejaung K; Kim SH; Suh-Kim H; Kim SS
    Cell Transplant; 2013; 22(5):855-70. PubMed ID: 22472631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.
    Suzuki M; McHugh J; Tork C; Shelley B; Hayes A; Bellantuono I; Aebischer P; Svendsen CN
    Mol Ther; 2008 Dec; 16(12):2002-10. PubMed ID: 18797452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
    Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
    Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
    Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
    J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis.
    Boucherie C; Schäfer S; Lavand'homme P; Maloteaux JM; Hermans E
    J Neurosci Res; 2009 Jul; 87(9):2034-46. PubMed ID: 19267424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis.
    Uccelli A; Milanese M; Principato MC; Morando S; Bonifacino T; Vergani L; Giunti D; Voci A; Carminati E; Giribaldi F; Caponnetto C; Bonanno G
    Mol Med; 2012 Jul; 18(1):794-804. PubMed ID: 22481270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells.
    López-González R; Kunckles P; Velasco I
    Cell Transplant; 2009; 18(10):1171-81. PubMed ID: 19660174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
    Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
    Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS.
    Suzuki M; McHugh J; Tork C; Shelley B; Klein SM; Aebischer P; Svendsen CN
    PLoS One; 2007 Aug; 2(8):e689. PubMed ID: 17668067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF-overexpressing human umbilical cord mesenchymal stem cell-derived motor neurons improve motor function and prolong survival in amyotrophic lateral sclerosis mice.
    Wang J; Hu W; Feng Z; Feng M
    Neurol Res; 2021 Mar; 43(3):199-209. PubMed ID: 33076784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis.
    Vercelli A; Mereuta OM; Garbossa D; Muraca G; Mareschi K; Rustichelli D; Ferrero I; Mazzini L; Madon E; Fagioli F
    Neurobiol Dis; 2008 Sep; 31(3):395-405. PubMed ID: 18586098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice.
    Kim H; Kim HY; Choi MR; Hwang S; Nam KH; Kim HC; Han JS; Kim KS; Yoon HS; Kim SH
    Neurosci Lett; 2010 Jan; 468(3):190-4. PubMed ID: 19879334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.